Inhaled salmeterol/fluticasone propionate: A guide to its use in asthma

Reynolds N.A., Lyseng-Williamson K.A., Wiseman L.R., Inhaled salmeterol/fluticasone propionate: A review of its use in asthma, Drugs, 65, 12, pp. 1715-1734, (2005)

GlaxoSmithKline, Advair Diskus 100/50, 250/50, 500/50 prescribing information, (2007)

Kirby S., Falcoz C., Daniel M.J., Et al., Salmeterol and fluticasone propionate given as a combination: Lack of systemic pharmacodynamic and pharmacokinetic interactions, Eur J Clin Pharmacol, 56, pp. 781-791, (2001)

Bateman E.D., Boushey H.A., Bousquet J., Et al., Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma controL study, Am J Respir Crit Care Med, 170, 8, pp. 836-844, (2004)

Strand A.M., Luckow A., Initiation of maintenance treatment of persistent asthma: Salmeterol/fluticasone propionate combination treatment is more effective than inhaled steroid alone. Danish INitiative for Asthma treatment, Respir Med, 98, 10, pp. 1008-1015, (2004)

Nelson H.S., Wolfe J.D., Gross G., Et al., Efficacy and safety of fluticasone propionate 44 μg/salmeterol 21 μg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment, Ann Allergy Asthma Immunol, 91, 3, pp. 263-269, (2003)

Murray J., Rosenthal R., Somerville L., Et al., Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting β2-agonists, Ann Allergy Asthma Immunol, 93, 4, pp. 351-359, (2004)

Bergmann K.-C., Lindemann L., Braun R., Et al., Salmeterol/fluticasone propionate (50/250 μg) combination is superior to double dose fluticasone (500 μg) for the treatment of symptomatic moderate asthma, Swiss Med Wkly, 134, 3-4, pp. 50-58, (2004)

Johansson G., McIvor R.A., D'Ambrosio F.P., Et al., Comparison of salmeterol/fluticasone propionate combination with budesonide in patients with mild-to-moderate asthma, Clin Drug Invest, 21, 9, pp. 633-642, (2001)

Shapiro G., Lumry W., Wolfe J., Et al., Combined salmeterol 50 μg and fluticasone propionate 250 μg in the Diskus device for the treatment of asthma, Am J Respir Crit Care Med, 161, pp. 527-534, (2000)

Reynolds N.A., Lyseng-Williamson K.A., Wiseman L.R., Inhaled salmeterol/fluticasone propionate: A review of its use in asthma, Drugs, 65, 12, pp. 1715-1734, (2005)

GlaxoSmithKline, Advair Diskus 100/50, 250/50, 500/50 prescribing information, (2007)

Kirby S., Falcoz C., Daniel M.J., Et al., Salmeterol and fluticasone propionate given as a combination: Lack of systemic pharmacodynamic and pharmacokinetic interactions, Eur J Clin Pharmacol, 56, pp. 781-791, (2001)

Bateman E.D., Boushey H.A., Bousquet J., Et al., Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma controL study, Am J Respir Crit Care Med, 170, 8, pp. 836-844, (2004)

Strand A.M., Luckow A., Initiation of maintenance treatment of persistent asthma: Salmeterol/fluticasone propionate combination treatment is more effective than inhaled steroid alone. Danish INitiative for Asthma treatment, Respir Med, 98, 10, pp. 1008-1015, (2004)

Nelson H.S., Wolfe J.D., Gross G., Et al., Efficacy and safety of fluticasone propionate 44 μg/salmeterol 21 μg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment, Ann Allergy Asthma Immunol, 91, 3, pp. 263-269, (2003)

Murray J., Rosenthal R., Somerville L., Et al., Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting β2-agonists, Ann Allergy Asthma Immunol, 93, 4, pp. 351-359, (2004)

Bergmann K.-C., Lindemann L., Braun R., Et al., Salmeterol/fluticasone propionate (50/250 μg) combination is superior to double dose fluticasone (500 μg) for the treatment of symptomatic moderate asthma, Swiss Med Wkly, 134, 3-4, pp. 50-58, (2004)

Johansson G., McIvor R.A., D'Ambrosio F.P., Et al., Comparison of salmeterol/fluticasone propionate combination with budesonide in patients with mild-to-moderate asthma, Clin Drug Invest, 21, 9, pp. 633-642, (2001)

Shapiro G., Lumry W., Wolfe J., Et al., Combined salmeterol 50 μg and fluticasone propionate 250 μg in the Diskus device for the treatment of asthma, Am J Respir Crit Care Med, 161, pp. 527-534, (2000)